Article
Human iPSC modeling reveals mutation-specific responses to gene therapy in Best disease
2019-10-08
Abstract excerpt
Dominantly inherited disorders are not typically considered therapeutic candidates for gene augmentation. Here, we utilized patient-specific induced pluripotent stem cell-derived retinal pigment epithelium (iPSC-RPE) to test the potential of gene augmentation to treat Best disease, a dominant macular dystrophy caused by over 200 missense mutations in BEST1 . Gene augmentation in iPSC-RPE fully restored BEST1 calc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a98e2234-6180-582d-9f40-fc3f682a1e8e
- DOI
- 10.1101/796581
